Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management

The aim of the study is to assess the cost-effectiveness of telemedicine in the care of chronic diabetic foot ulcers.

Patients will be randomized into 2 groups: 1/conventional care group with iterative visits to diabetes specialist or 2/innovative care (telemedicine group).

the health insurance system perspective is adopted.

Inclusion Criteria:

• Patients with type 1 or 2 diabetes, at least 18 years old

• Patient with a diabetic foot wound :

  • Acute or chronic (evolving for at least 30 days)
  • size ≤ to 3 cm²
  • Level I, II or III, stage A or B, excluding stages C and D from the University of Texas Wound Classification Systems

• Person affiliated to French Health insurance or equivalent

• Person having signed freely the consent form after receiving sufficient information

• Treatment compliance and 6 months follow-up feasible

Exclusion Criteria:

• Patient with a ischemic wound: Ankle-Brachial Index (ABI) <0.9 or Transcutaneous oxygen pressure (TcpO2) < 30 mmHg (stage C and D from the University of Texas Wound Classification Systems)
• Patient with emergency hospitalization indication whatever the reasons.
• Person deprived of liberty by a legal or administrative decision, patients in emergency and people hospitalised without consent and who are not protected by law.
• Pregnant or breastfeeding women
• Patient currently participating in another telemedicine research protocol (such as : Study on the impact of Telemedicine on the management of patients with type 1 diabetes (TELEDIAB-3))